TEVA PHARMACDRNTT

TEVA PHARMACDRN

46.400BRLD
−1.260−2.64%
At close at Feb 18, 20:21 GMT
BRL
No trades
See on Supercharts
Market capitalization
‪113.28 B‬BRL
−9.149BRL
‪−10.32 B‬BRL
‪103.99 B‬BRL
‪1.13 B‬
Beta (1Y)
−0.96

About TEVA


CEO
Richard Francis
Headquarters
Tel Aviv
Founded
1901
ISIN
BRT1EVBDR000
FIGI
BBG00XXWQ6X2
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Performance
‪−22%‬
‪−11%‬
‪0%‬
‪11%‬
‪22%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−9.00 B‬‬
‪0.00‬
‪‪9.00 B‬‬
‪‪18.00 B‬‬
‪‪27.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−9.00 B‬‬
‪0.00‬
‪‪9.00 B‬‬
‪‪18.00 B‬‬
‪‪27.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−9.00 B‬‬
‪0.00‬
‪‪9.00 B‬‬
‪‪18.00 B‬‬
‪‪27.00 B‬‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪30.00 B‬‬
‪‪60.00 B‬‬
‪‪90.00 B‬‬
‪‪120.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Feb 11, 2026
2021
2022
2023
2024
2025
‪0.00‬
‪4.00‬
‪8.00‬
‪12.00‬
‪16.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
T
TEVA.GJ
Teva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026
Yield to maturity
7.69%
Maturity date
Feb 1, 2026
T
TFAC
TEVA P.FI.NL III 16/46
Yield to maturity
7.32%
Maturity date
Oct 1, 2046
T
US88163VAD1
TEVA PHARM.FIN. 2036
Yield to maturity
6.11%
Maturity date
Feb 1, 2036
T
TFAB
TEVA P.FI.NL III 16/26
Yield to maturity
5.77%
Maturity date
Oct 1, 2026
T
XS181372460
TEVA PH.F.NL.II 18/25
Yield to maturity
4.50%
Maturity date
Mar 1, 2025

Explore more bonds